VBI Vaccines Inc (VBIV) Down 2.46% in Premarket Trading

VBI Vaccines Inc (VBIV) is lower by Thursday morning, with the stock decreasing -2.46% in pre-market trading to 1.19. VBIV's short-term technical score of 1 indicates that the stock has traded less bullishly over the last month than 99% of stocks on the market. In the Biotechnology industry, which ranks 131 out of 146 industries, VBIV ranks higher than 1% of stocks. VBI Vaccines Inc has fallen 3.17% over the past month, closing at $1.27 on August 10. During this period of time, the stock fell as low as $1.19 and as high as $1.35. VBIV has an average analyst recommendation of Strong Buy. The company has an average price target of $33.03.

VBIV has an Overall Score of 31. Find out what this means to you and get the rest of the rankings on VBIV!

See Full VBIV Report

VBI Vaccines Inc has a Long-Term Technical rank of 1. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 99% of the market scoring higher. In the Biotechnology industry which is number 131 by this metric, VBIV ranks better than 131% of stocks.

Important Dates for Investors in VBIV:

-VBI Vaccines Inc is set to release earnings on 2023-11-12. Over the last 12 months, the company has reported EPS of $-8.58. -We do not have a set dividend date for VBI Vaccines Inc at this time. Click Here To Get The Full Report on VBI Vaccines Inc (VBIV)